Uncovering the mechanism of action of aspirin in HCC chemoprevention.
作者信息
Roehlen Natascha, Baumert Thomas F
机构信息
Inserm, U1110, Institute de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France; Université de Strasbourg, 67000 Strasbourg, France.
Inserm, U1110, Institute de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France; Université de Strasbourg, 67000 Strasbourg, France; IHU Strasbourg, Pole Hépato-digestif, Hopitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
出版信息
EBioMedicine. 2019 Aug;46:21-22. doi: 10.1016/j.ebiom.2019.07.047. Epub 2019 Aug 6.
Abstract
摘要
相似文献
1
Uncovering the mechanism of action of aspirin in HCC chemoprevention.
EBioMedicine. 2019 Aug;46:21-22. doi: 10.1016/j.ebiom.2019.07.047. Epub 2019 Aug 6.
2
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma-ready for their use?
Aliment Pharmacol Ther. 2021 Sep;54(6):850-851. doi: 10.1111/apt.16556.
3
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.
Aliment Pharmacol Ther. 2021 Sep;54(6):852-853. doi: 10.1111/apt.16568.
4
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Clin Mol Hepatol. 2022 Jul;28(3):380-395. doi: 10.3350/cmh.2021.0366. Epub 2022 Jan 13.
5
An aspirin a day: the allure (and distraction) of chemoprevention.
J Natl Cancer Inst. 2012 Dec 5;104(23):1782-4. doi: 10.1093/jnci/djs462. Epub 2012 Nov 28.
6
Chemopreventive strategies in hepatocellular carcinoma.
Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):45-54. doi: 10.1038/nrgastro.2013.143. Epub 2013 Aug 13.
7
Hepatocellular Carcinoma Chemoprevention with Generic Agents.
Semin Liver Dis. 2022 Nov;42(4):501-513. doi: 10.1055/a-1942-6693. Epub 2022 Sep 14.
8
Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention.
J Hepatol. 2021 Nov;75(5):1217-1227. doi: 10.1016/j.jhep.2021.07.025. Epub 2021 Jul 31.
9
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Sci Rep. 2018 Mar 21;8(1):4968. doi: 10.1038/s41598-018-23343-0.
10
Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study.
World J Gastroenterol. 2019 Jul 28;25(28):3798-3807. doi: 10.3748/wjg.v25.i28.3798.
引用本文的文献
1
Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
Int J Mol Sci. 2024 Feb 21;25(5):2525. doi: 10.3390/ijms25052525.
2
Liver cell circuits and therapeutic discovery for advanced liver disease and cancer.
C R Biol. 2021 Nov 15;344(3):233-248. doi: 10.5802/crbiol.64.
3
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.
J Clin Med. 2020 Nov 25;9(12):3817. doi: 10.3390/jcm9123817.
本文引用的文献
1
Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma.
EBioMedicine. 2019 Jul;45:168-180. doi: 10.1016/j.ebiom.2019.06.048. Epub 2019 Jul 2.
2
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.
Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.
3
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
JAMA Oncol. 2018 Dec 1;4(12):1683-1690. doi: 10.1001/jamaoncol.2018.4154.
4
Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
Acta Pharmacol Sin. 2019 Jan;40(1):122-132. doi: 10.1038/s41401-018-0014-x. Epub 2018 Jun 20.
5
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.
Int J Cancer. 2017 Dec 15;141(12):2571-2584. doi: 10.1002/ijc.31022. Epub 2017 Sep 14.
6
Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
Oncogene. 2017 Dec 14;36(50):6895-6905. doi: 10.1038/onc.2017.291. Epub 2017 Aug 28.
7
Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
Gut. 2018 Apr;67(4):606-615. doi: 10.1136/gutjnl-2016-313584. Epub 2017 Apr 25.
8
Hepatocellular carcinoma.
Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18.
9
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
J Natl Cancer Inst. 2012 Dec 5;104(23):1808-14. doi: 10.1093/jnci/djs452. Epub 2012 Nov 28.
10
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):E2165-72. doi: 10.1073/pnas.1209182109. Epub 2012 Jul 2.
Zotero 插件